New Jersey Doctor Charged in 58-Count Indictment with Distributing Opioids in Exchange for Sexual Favors and Defrauding New Jersey Medicaid
U.S. Attorney’s Office, District of New Jersey
NEWARK, N.J. – A New Jersey doctor was charged in a 58-count indictment with distributing opioids without a legitimate medical purpose, maintaining a drug-involved premises, and defrauding New Jersey Medicaid by billing for visits that never happened, Senior Counsel Philip Lamparello announced today.
Ritesh Kalra, 52, of Secaucus, New Jersey, was previously charged by criminal complaint in July 2025, and now stands charged by indictment with additional offenses, including 36 counts of distributing opioids outside the usual course of professional practice and not for a legitimate medical purpose, one count of maintaining a drug-involved premises, and 21 counts of health care fraud. Kalra appeared for an arraignment and initial appearance on the indictment today before U.S. District Judge Michael E. Farbiarz in Newark federal.
“The additional charges against Dr. Kalra demonstrate that our Office will continue to pursue justice for victims of the opioid epidemic in New Jersey by prosecuting doctors who, as alleged, use their positions of trust to fuel addiction and exploit vulnerable patients. Physicians who defraud New Jersey’s Medicaid Program for their own personal gain will be held accountable.”
- Senior Counsel Philip Lamparello
“Doctors know the devastation opioid addiction can wreak when left unchecked. Allegedly, Dr. Kalra used his position of power for financial gain, fabricating fake appointments, and in some cases, demanding sexual favors in return for prescriptions. The FBI and its partners work tirelessly against such abuses of power, to ensure the abuser is no longer able to victimize patients. This indictment serves as a warning to others that a prescription pad is not a license to destroy lives,” stated FBI-Newark Special Agent in Charge Stefanie Roddy.
According to documents filed in the case and statements made in court:
Dr. Kalra, an internist in Fair Lawn, New Jersey, allegedly operated a pill mill out of his medical office, where he routinely prescribed high-dose opioids—including oxycodone and promethazine with codeine—to patients without a legitimate medical purpose. Between January 2019 and February 2025, Kalra issued more than 31,000 prescriptions for oxycodone, including days when he wrote upwards of 50 prescriptions. Several of Kalra’s former employees reported that female patients complained that Kalra touched them sexually and demanded sexual favors of them in exchange for opioids. One patient described being sexually assaulted by Kalra on multiple occasions, including forced anal sex during clinical appointments. Another patient continued to receive opioid prescriptions from Kalra when the patient was incarcerated at Essex County Correctional Facility and had no contact with Dr. Kalra.
Kalra also allegedly billed for in-person office visits that never occurred. As part of the health care fraud scheme, Kalra’s electronic medical records allegedly contained false progress notes listing fabricated dates of service, and included examination notes that were generally identical from visit to visit and did not record vital signs.
Each of the 36 distribution counts carries a maximum penalty of 20 years in prison and a $1 million fine. The charge of maintaining a drug-involved premises carries a maximum penalty of 20 years in prison and a $500,000 fine. Each of the 21 health care fraud counts is punishable by a maximum potential penalty of 10 years in prison and a $250,000 fine, or twice the gross profit or loss caused by the offense, whichever is greatest.
Individuals who believe they may be victims of Dr. Kalra or have information about this case may contact the FBI at 1-800-CALL-FBI (225-5324) or by email at NK-Victim-Assistance@fbi.gov.
Senior Counsel Philip Lamparello credited the following law enforcement organizations with the investigation leading to today’s charges: the Federal Bureau of Investigation, under the direction of Special Agent in Charge Stefanie Roddy; the Drug Enforcement Administration, New Jersey Field Division, under the direction of Special Agent in Charge Towanda Thorne-James; the U.S. Department of Health and Human Services Office of Inspector General, under the direction of Special Agent in Charge Naomi Gruchacz; the Internal Revenue Service—Criminal Investigation, under the direction of Special Agent in Charge Jenifer Piovesan; the Social Security Administration Office of Inspector General, under the direction of Special Agent in Charge Amy Connelly; the New Jersey Office of the Attorney General Division of Criminal Justice; and the Fair Lawn Police Department.
The government is represented by Assistant U.S. Attorney Katherine M. Romano, Chief of the General Crimes Unit, and Assistant U.S. Attorney Jessica R. Ecker of the Health Care Fraud and Opioids Enforcement Unit in Newark.
The charges and allegations contained in the indictment are merely accusations, and the defendant is presumed innocent unless and until proven guilty.